ArapS., GironA. M., MitreA. I.: A tobramicina en dose unica diaria no trattamento das infectado tratto urinario. Rev. Bras. Clin. Terap., 7; 265–267 (1979).
2.
BaileyR. R., AbbottG. D.: Treatment of urinary tract infection with a single dose of amoxicillin. Nephron, 18; 316 (1977).
3.
BendushC. L., WeberR.: Tobramycin sulfate: a summary of worldwide experience form clinical trials. J. Infect. Dis. (suppl.), 134; 5219 (1976).
4.
BrumettR. E., MeikleM. M., VernonJ. A.: Atoxycity of tobramycin in guinea pigs. Arch. Otoryngol., 94; 59–63 (1971).
5.
CipulloJ. P., AlbertoL., AcajabaR., PozettiJ. M., ZollaP. A., PereiraJ. E.: Tobramycin in single daily doses for the treatment of acute urinary tract infection. Rev. Bras. Med., 36; 9 (1979).
6.
FangL. S. T.: Efficacy of single dose and convetional amoxicillin therapy in urinary tract infection localized by antibody coacted bacteria. N. Engl. J. Med., 298; 413 (1978).
7.
LandesR. R., MelnckI., HofmanA., FehrenbakerL.: Tobramycin, a new aminoglycoside antibiotic: experience in urinary tract infection. South. Med. J., 68; 116–117 (1975).
8.
PrestonD. A., WickW. E.: Preclinical assessment of the antibacterial activity of nebramycin factor 6. Antimicrob. Agents Chemoter., 19; 322–327 (1971).
9.
Report on the National Survey of Infection in Hospitals 1980-1981. J. Hosp. Inf., 2 (suppl.).
